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The various plectin isoforms are among the major
crosslinking elements of the cytoskeleton. The impor-
tance of plectin in epithelia is convincingly supported
by the severe skin blistering observed in plectin-de¢-
cient humans and mice. Here, we identi¢ed plectin 1a
(4 500 kDa), a full length plectin variant containing
the sequence encoded by the alternative ¢rst exon 1a,
as the isoform most prominently expressed in human
and mouse keratinocytes. In skin sections and cultured
keratinocytes, plectin 1a was shown to colocalize with
hemidesmosomal structures. In contrast, a second iso-
form expressed in epithelia, plectin 1c, di¡ering from
1a merely by a short N-terminal sequence, colocalized
with microtubules. Expression of plectin 1a, but not of
its N-terminal fragment alone, or of a third alternative
full length isoform (plectin 1), restored the reduced
number of hemidesmosome-like stable anchoring con-
tacts in cultured plectin-null keratinocytes. Our results
show for the ¢rst time that di¡erent isoforms of a cyto-
linker protein expressed in one cell type perform dis-
tinct functions. Moreover, the identi¢cation of plectin
1a as the isoform defects in which cause skin blistering
in plectin-related genetic diseases, such as epidermolysis
bullosa simplex MD and epidermolysis bullosa simplex
Ogna, could have implications for the future develop-
ment of clinical therapies for patients. Key words: cyto-
linkers/epidermolysis bullosa simplex/muscular dystrophy/
plakins/plectin isoforms. J Invest Dermatol 120:189 ^197,
2003
P
lectin, one of the major crosslinking elements of the
cytoskeleton, belongs to a family of structurally and
in part functionally related proteins referred to as pla-
kins or cytolinkers (for review see Wiche, 1998; Fuchs
and Karakesisoglou, 2001; Leung et al, 2002). Plectin
mediates network formation of intermediate ¢laments (IFs), the
interlinking of IFs with microtubules and micro¢laments, as well
as the anchoring of IFs to the plasma and nuclear membrane. A
novel important role of plectin as regulator of actin cytoskeleton
dynamics has recently been demonstrated (Andr et al, 1998).
There is growing evidence for an essential role of plectin in
epithelial tissues. In strati¢ed epithelia the protein has been loca-
lized at basal cell surface membranes and in peripheral areas
of epithelial cells in all cell layers (Wiche et al, 1984). It is found
associated with hemidesmosomes and cytokeratin ¢laments in
the basal epithelial compartment of skin, and with desmosomal
structures in polarized simple epithelial cells. Direct interactions
of plectin with the hemidesmosomal integrin subunit b4 at mul-
tiple molecular sites (Rezniczek et al, 1998; Nievers et al, 2000) and
with desmoplakin (Eger et al, 1997) have been demonstrated.
The importance of plectin in epithelia has also been demon-
strated convincingly in plectin knock-out mice. These animals
exhibit severe skin blistering combined with a reduction in
the number of hemidesmosomes, and in addition they show
abnormalities in skeletal and heart muscle (Andr et al, 1997).
Similar disorders were found in patients su¡ering from epider-
molysis bullosa simplex (EBS) MD.This autosomal recessive dis-
ease, caused by mutations in the plectin gene, is characterized by
intraepidermal blistering at the level of basal keratinocytes asso-
ciated with late-onset muscular dystrophy (for review see Rouan
et al, 2000). A dominant form of the disease, EBS-Ogna, leads to
skin changes in the absence of muscular symptoms in the patients
(Koss-Harnes et al, 2002).
Cloning and sequencing of rat, human, and mouse plectin
cDNA (Liu et al, 1996; McLean et al, 1996; Fuchs et al, 1999)
revealed a polypeptide chain sequence that is consistent with a
three-domain structural model, where a long central rod domain,
having an a-helical coiled-coil conformation, is £anked by glob-
ular N- and C-terminal domains. The N-terminal domain of
plectin contains an actin-binding domain (ABD) shared by a
large superfamily of actin-binding proteins (Stradal et al, 1998).
The ABD of plectin has recently been found to be multifunc-
tional, binding not only to actin but also to the integrin subunit
b4 (Rezniczek et al, 1998; Geerts et al, 1999) and to itself (Fontao
et al, 2001); another integrin b4 binding site has been mapped
to the C-terminal domain of plectin (Rezniczek et al, 1998). In
addition, the C-terminal part of the protein harbors an IF-bind-
ing site that was shown to mediate the interaction of plectin with
vimentin and cytokeratins (Nikolic et al, 1996; Steinb˛ck et al,
2000). A detailed analysis of the genomic exon-intron organiza-
tion of the murine plectin gene revealed an unusual 50 transcript
complexity of plectin isoforms, with a total of 11 alternatively
spliced ¢rst exons upstream of their common exon 2 (Fuchs
et al, 1999).
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In this study we identi¢ed plectin 1a, the isoform containing
sequences encoded by the alternative ¢rst exon 1a, as the isoform
most prominently expressed in human keratinocytes. Using
isoform-speci¢c antibodies, plectin 1a was shown to localize spe-
ci¢cally to hemidesmosomal structures in mouse skin sections
and cultured mouse keratinocytes, in contrast to the other major
isoform expressed in keratinocytes, plectin 1c. Only full length
versions of plectin 1a but not of a third alternative isoform (plec-
tin 1) were found su⁄cient to restore the reduced number of
hemidesmosome-like stable anchoring contacts (SACs), a feature
characteristic of plectin-de¢cient keratinocytes. This is the ¢rst
time that di¡erent isoforms of plectin, and of cytolinkers in gen-
eral, are shown to have distinct subcellular localization and pre-
sumably functions within one cell type (keratinocytes). We
suggest that plectin 1a is the speci¢c isoform responsible for the
skin blistering symptom observed in plectin-related hereditary
diseases.
MATERIALS AND METHODS
Cell culture Immortalized plectin (þ /þ ) and (/) mouse
keratinocyte cell cultures were established from plectin (þ /þ )/p53
(/) and plectin (/)/p53 (/) mice, which were obtained from
plectin (þ /)/p53 (/) intercrosses (Metz et al, 1995). This method
generates a de¢ned mutation (absence of p53) that facilitates
immortalization of cells that otherwise are di⁄cult to immortalize. Mice
carrying a mutated allele of plectin were generated as described previously
(Andr et al, 1997), and p53 (/) blastocysts were kindly provided by E.
Wagner (IMP, Vienna, Austria). Keratinocyte cell lines were established
from 1-d-old mice and routinely cultured as described previously (Troy
and Turksen, 1999). Human primary keratinocytes were kindly provided
by I. Schuster (Novartis, Vienna, Austria) and E. Tschachler (AKH,
Vienna, Austria).
Antibodies The following primary immunoreagents were used: rabbit
antiserum (no. 9) raised against a recombinant rat plectin protein
fragment corresponding to exons 9^12 (N-term.), and mouse antiserum
(123C) to a recombinant fragment corresponding to the C-terminal
repeat 5 domain of rat plectin (C-term.), both prepared and kindly
provided by B. Nikolic (this laboratory); isoform-speci¢c a⁄nity-puri¢ed
rabbit antisera to an exon 1a peptide (anti-E1a) (Rezniczek et al, 1998), and
to a GST-fusion protein containing the N-terminal sequence M1^S17 of
plectin 1c (12); rabbit antiplectin antiserum (no. 46) (Wiche et al, 1984); rat
monoclonal antihuman integrin b4 antibody (346^11 A) kindly provided
by S.J. Kennel, Oak Ridge Laboratories, TN; rat monoclonal antihuman
integrin a6 (GoH3, PharMingen, San Diego, CA); mouse monoclonal
antivinculin (clone vin 11^5) and antitubulin (clone B-5-1-2) antibodies
(both from Sigma, St. Louis, MO); and undiluted hybridoma supernatant
of monoclonal antimyc 1^9E10.2 antibody (ATCC Manassas, VA). As
secondary antibodies horseradish-peroxidase-labeled goat antimouse and goat
antirabbit IgGs (Bio-Rad, Hercules, CA) were used for immunoblotting, and
Texas Red conjugated antibodies (Jackson Immuno-Research Laboratories,
West Grove, PA) and Alexa Fluort 488 antibodies (Molecular Probes,
Eugene, OR) were used for immuno£uorescence microscopy.
RNase protection assay Isolation of total RNA, RNase protection
analysis, and quanti¢cation of relative signal intensities were performed as
described previously (Fuchs et al, 1999). Probes speci¢c to human exons 1a
(GenBank accession no AF330791) were derived from plectin genomic
clones HPG24, HPG25, and HPG29 (Liu et al, 1996) by degenerative
polymerase chain reaction (PCR). A probe speci¢c to exon 1 was
subcloned from human plectin cDNA clones pCGL25 and pCGL53 (Liu
et al, 1996). The E1c-speci¢c riboprobe was PCR-ampli¢ed from human
brain QUICK-Clonet cDNA (Clontech Laboratories, Palo Alto, CA). A
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) speci¢c probe (gift
from M. Busslinger, IMP, Vienna, Austria) was truncated to produce a
signal short enough to serve as loading control.
Immunoblotting Cells were lyzed in 20 mM Tris (pH 7.4), 150 mM
NaCl, 1% Triton X-100, 2.5 mM ethylenediamine tetraacetic acid,
2.5 mM ethyleneglycol-bis(b-aminoethyl ether)-N,N,N0,N0-tetraacetic
acid, and protease inhibitors. Samples were subjected to sodium dodecyl
sulfate 4% polyacrylamide gel electrophoresis; transfer and detection of
proteins were performed as described previously (Eger et al, 1997).
Transient transfection experiments Transfections of immortalized
plectin (/) keratinocytes were performed using LIPOFECTAMINEt
reagent (LifeTechnologies, San Diego, CA) according to the manufacturer’s
instructions. Plasmids pBK23 and pGR99 encoding plectin fragments
corresponding to exons 1a^14 (Andr et al, 1998) and exons 2^15,
respectively, and pIK25, pIK26, and pPF50, each encoding full length
versions of rat plectin starting with exon 1a-, exon 1-, and exon 1c-
speci¢c sequences, respectively, were used for transfections. pIK25 was
generated by excision of a full length (13.7 kb) rat plectin cDNA fragment
from plasmid pIK14 (obtained by combining PCR-ampli¢ed and plectin
cDNA fragments; I. Kornacker, 2000, PhD thesis, University of Vienna)
and cloning into expression vector pIK23. pIK23 was derived from a
pBluescriptsII KS þ vector (Stratagene, La Jolla, CP), which contained
the human K14 promoter, the generic intron, and the human growth
hormone 30 UTR/polyadenylation site of vector pK14iA (Kucera et al,
1996). pIK26 was generated by excision of full length (14.1 kb) rat plectin
isoform 1 cDNA from plasmid pBN13 (I. Kornacker, 2000), and cloning
into pIK23. The cDNA sequence encoding full length plectin 1c was
PCR-cloned using mouse cDNA (Marathon-Ready, Clontech). pPF50
was generated by subcloning this sequence into a modi¢ed expression
plasmid pEGFPN2 (Clontech) in which the CMV promoter was removed
and replaced by the human K14 promoter used in pIK23. All expression
plasmid inserts were fully sequenced.
Immuno£uorescence microscopy Cells and 2 mm cryosections of
murine skin were processed for immuno£uorescence microscopy as
described previously (Rezniczek et al, 1998). Specimens were viewed in an
LSM 510 laser scanning microscope (Zeiss, Oberkochen, Germany).
RESULTS AND DISCUSSION
The major isoforms of plectin expressed in primary
keratinocytes are full length versions of plectin 1a and
plectin 1c In a recent study on plectin isoform expression in
mouse tissues, a dominance of exon-1a-containing isoforms was
observed in epithelial tissues (Fuchs et al, 1999). Con¢rming this,
we found, using quantitative RNase protection assays, that the
predominant plectin isoforms expressed in primary human
keratinocytes contained exon 1a sequences (71% of all transcripts
detected), followed by variants containing exon 1c (22%), exon 1
(4%), and exon 1b (1%) sequences (Fig 1A, B). To distinguish the
two major isoforms plectin 1a and plectin 1c, and dissect their
possible functions in vivo, we generated plectin-1c-speci¢c
antibodies (anti-E1c) to be used along with previously prepared
antibodies (Rezniczek et al, 1998) speci¢cally recognizing
isoform 1a (anti-E1a). First we assessed whether plectin 1a and
plectin 1c were expressed in mouse keratinocytes as full length
versions of the protein. In analysing cell lysates from
immortalized plectin (þ /þ ) and plectin (/) keratinocytes
we used two antisera (N-term. and C-term.), recognizing
epitopes in N- or C-terminal domains of plectin that are
common to all plectin isoforms, in addition to the isoform-
speci¢c antibodies. All four antisera detected proteins with an
apparent molecular mass of E500 kDa in plectin (þ /þ )
but not plectin (/) cells (Fig 1C). This clearly demonstrated
that in keratinocytes both isoforms were expressed as full length
versions of the protein. Proteins of smaller molecular mass were
not detected on these blots.
Di¡erential distribution of plectin isoforms 1a and 1c in
keratinocytes: association of plectin 1a with hemidesmosomal
structures On cryosections of plectin wild-type mouse skin,
antiplectin 1a (E1a) antibodies conspicuously stained the
basement membrane of the epidermis (Fig 2A). Intriguingly, a
punctated nature of this staining was revealed on grazing
sections of the basal keratinocyte cell surface at high
magni¢cation (Fig 2D). Similar results were obtained when
antiserum no. 46 with immunoreactivity predominantly towards
the rod domain of plectin was used (Fig 2B, E). Additionally, a
weak plectin-speci¢c staining of suprabasal epithelial cell layers
was observed. In contrast, plectin 1c was prominently expressed
at the periphery of cells in the suprabasal layers of the epidermis
(Fig 2C) and was detected only at low levels in basal
keratinocytes. The punctated staining pattern at the basal cell
surface characteristic of plectin 1a was not detectable with
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anti-E1c antibodies (Fig 2F). As the staining patterns observed
with antiserum 46 showed the features of both isoforms
combined, these data suggested that isoforms 1a and 1c both
contain the rod domain of the protein, but can be distinguished
by their distinct N-termini. Plectin (/) control keratinocytes
were negative in all cases (Fig 2G^I). The immunolocalization of
plectin 1a on cryosections of mouse skin was consistent with
immunogold electron microscopy data revealing plectin 1a
epitopes at hemidesmosomal structures and in association with
cytokeratin ¢laments in the basal epithelial compartment of rat
skin. Plectin 1a is probably targeted to these structures via its
integrin b4 binding site(s) and anchored to keratin ¢laments via
its terminal IF-binding site (Rezniczek et al, 1998).
To examine the intracellular localization of plectin isoforms 1a
and 1c in epithelial cells in more detail, we performed
immuno£uorescence microscopy of immortalized plectin (þ /
þ ) and plectin (/) mouse keratinocytes. Plectin was found
to colocalize with arrays of circular structures that were 1^4 mm
in diameter and varied in numbers depending on cell size (Fig 3).
These structures resembled SACs, which have been shown
to bear functional and compositional similarities to skin
hemidesmosomes (Carter et al, 1990). Indeed, using antiplectin
1a antibodies in combination with antibodies to the
hemidesmosomal integrin subunit proteins b4 and a6, we
observed colocalization of plectin 1a with both of these proteins
(Fig 3A^C,D^F, respectively).This colocalization appeared to be
partial, possibly re£ecting a heterogeneity of SACs and/or a
dependence of the recruitment of plectin 1a on the assembly
state or stability of these structures. SAC structures were also
assembled in plectin-de¢cient cells (Fig 3H); however, a
statistical analysis in cell cultures of the same passage number
revealed that only 12% of plectin (/) keratinocytes had
developed these structures, compared to 50% of plectin (þ /þ )
keratinocytes (Fig 3J). The expression levels of integrin b4, as
assessed by immunoblotting of cell lysates, were unchanged in
plectin (/) compared to keratinocytes (data not shown). This
indicated that the loss of plectin does not a¡ect the expression or
stability of other integral SAC components, but a¡ects SAC
formation.
A previous comparison of ¢broblasts derived from plectin
(þ /þ ) and (/) mice and of keratinocytes from normal
individuals and patients su¡ering from EBS-MD (Andr et al,
1998; Nievers et al, 2000) had revealed an augmentation of focal
adhesion contacts (FACs) in the plectin-de¢cient cells. Similarly,
we found an increase in the number of vinculin-positive FACs in
immortalized mouse plectin (/) keratinocytes compared to
(þ /þ ) control cells (Fig 4G; compare also B and E). The
generation of more FACs in plectin (/) keratinocytes might
result from a compensatory mechanism that cells use to cope
with a reduced adhesion to the substratum elicited by the
decrease or absence of SACs. Interestingly, double staining of
plectin 1a and vinculin revealed that plectin 1a hardly colocalized
with FACs (Fig 4A^C). This suggested that the association of
plectin 1a with SACs in cultured keratinocytes was speci¢c.
Figure1. Expression of plectin transcripts and full length plectin
isoforms 1a and 1c in keratinocytes. (A) Schematic representation of
plectin subdomains, isoforms, and exon allocation. Segments to which
functions have been assigned are indicated: ABD, actin binding domain,
integrin b4 binding sites; IF-BD, intermediate ¢lament binding site; cdc2,
phosphorylation site for p34cdc2. (B) RNase protection analyses of plectin
transcripts containing distinct ¢rst coding exons in keratinocytes. Total
RNA (10 mg) was analyzed using riboprobes speci¢c to exons 1 (E1), 1a
(E1a), 1b (E1b), and 1c (E1c). The GAPDH-speci¢c riboprobe was used to
control RNA loading. Riboprobes and protected fragments are shown.
Length of protected fragments: E1, 108 nt; E1a, 87 nt; E1b, 115 nt; E1c, 149
nt; GAPDH, 53 nt (left panel). Autoradiography signals were quanti¢ed
using a PhosphorImager. Values obtained for radiation levels over back-
ground were normalized for RNA loading and the radioactive guanine
content of the riboprobes. A transcript level of 100% refers to the sum of
values obtained for exons 1-, 1a-, 1b-, and 1c-containing transcripts
(right panel). nt, nucleotides; rel., relative; kerat., primary keratinocytes. (C)
Western blotting of cell lysates of immortalized plectin (+/+) and plectin
(/) mouse keratinocytes using antisera to the N-terminal (N-term.; no.
9), the C-terminal (C-term.; 123C), and the exon-1a- (E1a) and exon-1c-
encoded (E1c) domains of plectin.
Figure 2. Immuno£uorescence microscopy of cryosections of mur-
ine plectin (+/+) and (/) skin using anti-E1a, anti-E1c, and anti-
full length plectin (no. 46) antisera. Bars in (B) (representative of A^C
and G^I) and (E) (representative of D^F), 20 and 5 mm, respectively.
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Unlike plectin 1a, in plectin (þ /þ ) keratinocytes plectin 1c
was found associated with cytoskeletal ¢laments, which could be
identi¢ed as microtubules by double immuno£uorescence
microscopy using isoform-speci¢c antibodies (E1c) in
combination with antibodies to a-tubulin (Fig 5A^C). A
localization of plectin 1c in hemidesmosomal structures was
never observed. The ¢lamentous staining pattern detected with
plectin-1c-speci¢c antibodies was absent in plectin (/) cells
as expected, and the microtubule networks displayed no
major changes (Fig 5D^F), except for a possible tendency to
Figure 3. Localization of plectin 1a at SACs. (A)^(I) Immortalized plectin (+/+) and (/) keratinocytes were processed for double immuno£uores-
cence microscopy as described in the text. Anti-E1a antiserum (E1a), anti-integrin b4 (b4), and anti-integrin a6 (a6) antibodies were used. Bars in (F)
(representative of A^F) and in (I) (representative of G^I), 10 mm. Note that plectin 1a colocalized with integrin b4 and integrin a6 at SACs (arrows in A^
F) and that plectin (/) cells display a few SACs (H, I). (J) Numerical analysis of SACs in plectin (+/+) and (/) mouse keratinocytes (mK). Data points
represent individual cells. Sixty cells of each type were analyzed. Note that the number of SACs per cell varied with cell size and was reduced in plectin
(/) compared to (+/+) keratinocytes.
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higher microtubule density in plectin (/) cells. The
immunoreactivity occasionally observed in the nucleus of both
plectin (þ /þ ) and plectin (/) keratinocytes was assumed to
be nonspeci¢c.
Functional distinction of plectin isoforms due to distinct
rescue potentials in plectin-de¢cient keratinocytes The
di¡erential distribution of plectin variants and the speci¢c
association of plectin 1a with hemidesmosomal structures
suggested a keratinocyte-speci¢c function of this isoform.
Therefore, the potential of plectin 1a to reverse the phenotypes
of plectin-de¢cient keratinocytes was studied by transient
transfection experiments. First an N-terminal fragment of rat
plectin 1a (plectin 1a-14), which contained plectin’s ABD and had
previously been shown to restore the actin/FAC phenotype of
¢broblasts (Andr et al, 1998), was expressed in plectin (/)
cells. Double immuno£uorescence microscopy using plectin 1a-
and vinculin-speci¢c antibodies showed that the expression of
this fragment in plectin (/) keratinocytes led to a reduction
of FACs (Fig 6A^C). Almost no FACs could be seen in plectin-
1a-14-transfected cells compared to numerous vinculin-positive
FACs at the periphery of untransfected cells (Fig 6B). As
documented by statistical analysis of cells randomly chosen
from the same culture dishes, nontransfected plectin (/)
keratinocytes showed up to 160 FACs per cell, whereas in
transfected cells the number of FACs rarely exceeded 25 (Fig
6G). Furthermore, contrary to mock-transfected cells or cells
expressing another N-terminal plectin fragment that lacks the
domain corresponding to exon 1a (data not shown), about 90%
of E1a-14-transfected cells exhibited cellular protrusions (Fig 6A,
D, arrows), in which plectin 1a-14 was found to be accumulated.
This N-terminal fragment of plectin 1a was never found
associated with SACs, however, clearly demonstrating that this
part of the molecule, although being su⁄cient to reduce the
number of FACs per cell, does not colocalize with and has no
e¡ect on hemidesmosome-like structures. This is astonishing
because the N-terminal fragment comprised the ABD, which is
known to harbor one of plectin’s integrin b4 binding sites
(Rezniczek et al, 1998; Nievers et al, 2000). Thus, the localization
of plectin 1a to hemidesmosomes may require the additional
Figure 4. Di¡erential distribution of plectin 1a and FACs. (A)^(F) Double immuno£uorescence microscopy of immortalized plectin (+/+) and (/)
keratinocytes, using anti-E1a antiserum (E1a) and antivinculin (vinc) antibodies. Note that plectin 1a does not colocalize with FACs (arrows in A^C), but
shows partial colocalization with vinculin in FACs-free perinuclear regions; also the number of FACs was increased and FAC structures were more scattered
over the cells in plectin (/) keratinocytes (E) compared to (+/+) keratinocytes (B). Bar: 10 mm. (G) Numerical analysis of FACs in plectin (+/+) and
(/) mouse keratinocytes (mK). Data points represent individual cells.
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integrin b4 binding site identi¢ed in its C-terminus or other
functions provided by this domain, such as binding to
hemidesmosome-associated proteins of unknown identity.
In contrast to the N-terminal fragment, full length plectin 1a
expressed in plectin (/) keratinocytes showed association with
SACs in the vast majority of transfected cells (Fig 7A^C, arrows).
Interestingly, statistical analyses revealed that the number of SACs
detectable in these transfected (/) cells (8^52 SACs per cell)
was signi¢cantly increased compared to nontransfected cells (0^
2 SACs per cell; Fig 7G). Moreover, in some cases the number
of SACs per cell even exceeded the level of SACs in
nontransfected plectin (þ /þ ) cells (0^22 SACs per cell; Figs
7G, 3J). The vast majority of SAC-positive transfected cells
exhibited a spherical shape (Fig 7A) consistent with the
observation that none of these cells showed a signi¢cant number
of vinculin-positive FACs. This indicated that expression of the
full length version of plectin 1a was required for rescuing the
SAC phenotype of plectin (/) keratinocytes.
To assess whether the SAC rescue potential of plectin 1a
was speci¢c for this isoform, immortalized plectin-de¢cient
keratinocytes were transiently transfected with an expression
plasmid encoding a full length version of the alternative isoform
plectin 1c. Similar to endogenous plectin 1c of wild-type cells
(Fig 5A), plectin 1c expressed in transfected (/) cells was
found associated with ¢lamentous structures, and double
staining (E1c/a-tubulin) showed partial codistribution with
microtubules (Fig 5G^I); association with SACs or cytokeratin
14 (data not shown) was not observed. Likewise, when plectin
(/) keratinocytes were transfected with a full length version
of plectin 1, a third isoform of plectin expressed in epithelial
cells (see Fig 1), an association with structures resembling SACs
was not detected; instead, the nuclear region was intensively
stained and an association of plectin 1 with ¢lamentous
structures became apparent in perinuclear regions (Fig 7D^F).
Furthermore, in contrast to the accumulation of integrin b4 in
SACs of plectin-1a-expressing cells, transfection of cells with
plectin 1 cDNA resulted in a rather di¡use distribution of
integrin b4 (compare Fig 7B, E). Not a single plectin-1-
transfected cell was found in which SACs could be detected
(Fig 7I), clearly indicating that only plectin 1a was able to
Figure 5. Colocalization of plectin 1c with microtubules in mouse keratinocytes. (A)^(F) Double immuno£uorescence was carried out using anti-
E1c (E1c) antiserum, and antitubulin (tub) monoclonal antibodies. Note colocalization of plectin 1c and microtubules (A^C, arrows) in wild-type (+/+)
keratinocytes and in plectin-de¢cient (/) keratinocytes transfected with full length plectin 1c cDNA (G^I, arrows). Also note fully developed microtubule
networks in plectin (/) keratinocytes (E). Bar: 10 mm.
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restore the SAC phenotype of plectin-de¢cient keratinocytes.
Similar to plectin 1a and plectin 1a-14, however, plectin 1 was
found to reduce the number of FACs in plectin (^/^)
keratinocytes (Fig 7H). This suggests a regulatory mechanism
for the generation of FACs involving N-terminal sequences
other than those encoded by exon 1a, a notion supported by full
length plectin 1a’s absence from FACs. It should be noted that all
isoforms studied were expressed under the control of the K14
promoter over similar transfection periods with similar
transfection e⁄ciency, ensuring comparable expression levels. In
summary, these data showed that plectin 1a was speci¢cally
involved in the formation and/or stabilization of SACs,
whereas plectin 1, plectin 1c, and plectin 1a-14 had no e¡ects
on SACs.
The function of the 37 amino acid long exon 1a-encoded N-
terminal sequence unique to plectin 1a remains currently unclear.
It is unlikely that it plays a role as a direct hemidesmosomal
targeting signal considering that neither the fragment plectin 1a-
14 (Fig 6A, D) nor a GFP-fusion protein containing just the
1a-speci¢c sequence (data not shown) colocalized with
Figure 6. Transfection of cDNAs encoding N-terminal fragment plectin 1a-14 into immortalized plectin (^/^) mouse keratinocytes. (A)^(F)
Double immuno£uorescence microscopy was carried out using anti-exon 1a (E1a) antiserum, anti-integrin b4 (b4), and antivinculin (vinc) as primary im-
munoreagents. Note cellular protrusions in plectin (^/^) keratinocytes expressing plectin 1a-14 (arrows in A and D). Also, note partial colocalization of
plectin 1a-14 and vinculin in perinuclear regions (compare to Fig 4A^C). Bar: 25 mm. (G) Numerical analysis of FACs in transfected (^/^ mk E1a-14) and
nontransfected (/^ mk) immortalized plectin (^/^) keratinocytes. Data points represent individual cells. Note the reduction of FACs per cell upon trans-
fection of the N-terminal fragment E1a-14.
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hemidesmosomes in transfection assays. A more likely alternative
would be that this sequence a¡ects functions of plectin that
involve other molecular domains, such as those serving as
binding sites for plectin’s various interaction partners. Such sites
may reside in close vicinity to the 1a-speci¢c sequence, such as
in the immediately succeeding ABD, or in more remote
sequence regions that become a¡ected due to the folding of the
polypeptide chain. The latter would be consistent with our
preliminary observation that N-terminal recombinant fragments
containing the exon 1a- or exon 1c-encoded sequences and the
succeeding ABD showed equally e¡ective binding to the
cytoplasmic domain of integrin b4 when subjected to in vitro
binding assays (unpublished data). It is conceivable that a¡ected
sites may even be part of C-terminal plectin domains, as there is
evidence for intramolecular as well as intermolecular head-to-tail
interactions of plectin molecules. Furthermore, interactions
Figure 7. Transfection of cDNAs encoding full length plectin 1a (A^C) and full length plectin 1 (D^F) into immortalized plectin (^/^) mouse
keratinocytes. (A^F) Double immuno£uorescence microscopy was carried out using anti-exon 1a (E1a) antiserum, anti-integrin b4 (b4), and antimyc (E1)
monoclonal antibodies as primary immunoreagents. Overexpressed full length plectin 1a colocalized with integrin b4 at SACs (arrows in A^C). In cells
transfected with full length plectin 1 no SACs were detected (D^F); note ¢lamentous staining pattern in perinuclear regions. Bar: 20 mm. (G^I) Numerical
analyses of FACs (H) and SACs (G, I) in transfected and nontransfected (^/^ mk) immortalized plectin (^/^) keratinocytes. Data points represent individual
cells. Note the reduction of FACs per cell upon transfection of full length plectin 1, and the increase in SACs per cell upon transfection of full length plectin
1a, but not upon transfection of full length plectin 1.
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between N- and C-terminal domains may also occur in
oligomers formed by the lateral association of coiled-coil dimers
in an antiparallel fashion (Foisner and Wiche, 1987). This
complexity is likely to make it a challenging task for future
studies to unravel the molecular mechanisms of how plectin 1a-
speci¢c and other isoform-speci¢c N-terminal sequences
determine the di¡erent functions of plectin variants.
Because plectin (/) mice and keratinocytes derived from
these mice have a decreased number of hemidesmosomal
structures (Andr et al, 1997), plectin was proposed to function as
hemidesmosomal stabilizer (Rezniczek et al, 1998). In transient
transfection experiments in which full length plectin 1a was
expressed in plectin (/) keratinocytes, the hemidesmosomal
defect of these cells, which is believed to cause skin blistering in
EBS-MD patients, was rescued. Plectin 1a is therefore most likely
the plectin isoform, the defects in which are responsible for the
skin blistering observed in EBS-MD. This is further supported
by the observations that (i) neither full length plectin 1 nor 1c
were able to rescue the hemidesmosomal phenotype of plectin
(/) keratinocytes and (ii) endogenous plectin 1c was not
associated with hemidesmosomal structures.
In conclusion, our results suggest that defects in plectin 1a, the
major epithelial isoform, are responsible for the skin blistering
of plectin-de¢cient humans and mice. These ¢ndings might
be a ¢rst step towards understanding the function of plectin’s
unusual isoform diversity and could have implications for the
development of clinical therapies for EBS-MD patients in the
future.
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